Furthermore, the association of low UBE4B expression with worse patient outcomes in all patient subsets suggests that alternate mechanisms regulating UBE4B gene expression other than 1p36 deletion are likely involved in neuroblastoma tumors. The gene discussed is UBE4B; the disease is neuroblastoma.